Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms. Young children and older adults, especially those with certain underlying health conditions, are at higher risk for severe illness from RSV. Prophylaxis is available for children who qualify. For more information, contact your health care provider.
In week 19, RSV activity in children <5 years increased and was above levels observed at this time during typical seasonal activity.
No new RSV-associated outbreak was reported in week 19. A total of 9 RSV-associated outbreaks have been reported since week 30, 2021 (beginning on July 25, 2021).
In week 19, the percent of emergency department visits for RSV among children <5 years increased and was above levels observed at this time during typical seasonal activity.
In week 19, the percent of specimens testing positive for RSV increased. Levels were above those observed at this time during typical seasonal activity.
A statewide RSV surveillance system was implemented in Florida to support clinical decision-making for prophylaxis of premature infants.
The determination of unique seasonal and geographic trends of RSV activity in Florida has important implications for prescribing patterns for initiating prophylaxis to children at high risk for complications from RSV infection. The American Academy of Pediatrics currently recommends pre-approval for prophylactic treatment be made based on state surveillance data.
Florida’s RSV season is longer than the rest of the nation and has distinct regional patterns. The Florida Department of Health established regional RSV seasons based on activity thresholds provided by the Centers for Disease Control and Prevention. Currently, one of Florida’s five regions is in RSV season.
To learn more about RSV in Florida, please visit FloridaHealth.gov/RSV.